| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |